Most of the publications concerned about PRKAA1 polymorphisms focused on its significantly positive association with gastric cancer (GC) [9–11], as well as on breast cancer [12], but there are also some negative results [13–16]. This evidence concerns the gene PRKAA1 and breast carcinoma.